Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glioblastoma, IDH-wildtype manifesting as intracranial hemorrhage: A case report highlighting the clinical utility of digital polymerase chain reaction in integrated diagnoses.
Nikai Y, Satomi K, Saito K, Gomyo M, Matsushita Y, Kato K, Nagahama K, Isomura A, Hayashi A, Yamagishi Y, Sasaki N, Kobayashi K, Tsuchiya K, Nagane M, Ichimura K, Shibahara J. Nikai Y, et al. Among authors: kato k. Neuropathology. 2025 Jan 3. doi: 10.1111/neup.13025. Online ahead of print. Neuropathology. 2025. PMID: 39748727
Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma.
Shibayama T, Hayashi A, Toki M, Kitahama K, Ho YJ, Kato K, Yamada T, Kawamoto S, Kambayashi K, Ochiai K, Gondo K, Okano N, Melchor JP, Iacobuzio-Donahue CA, Sakamoto Y, Hisamatsu T, Shibahara J. Shibayama T, et al. Among authors: kato k. Sci Rep. 2024 Jul 6;14(1):15598. doi: 10.1038/s41598-024-65900-w. Sci Rep. 2024. PMID: 38971768 Free PMC article.
Novel THBS1::IGF1R fusion in myopericytic tumour.
Kato K, Yamashita K, Dobashi A, Togashi Y, Baba S, Ae K, Matsumoto S, Takeuchi K. Kato K, et al. Histopathology. 2024 Jul;85(1):197-201. doi: 10.1111/his.15186. Epub 2024 Apr 4. Histopathology. 2024. PMID: 38576274 No abstract available.
Epidemiology of Yellow Fever in Nigeria: Analysis of Climatic, Ecological, Socio-Demographic, and Clinical Factors Associated with Viral Positivity Among Suspected Cases Using National Surveillance Data, 2017-2023.
Akar SE, Nwachukwu W, Adewuyi OS, Ahumibe AA, Akanimo I, Okunromade O, Babatunde O, Ihekweazu C, Hitachi M, Kato K, Takamatsu Y, Hirayama K, Kaneko S. Akar SE, et al. Among authors: kato k. J Epidemiol Glob Health. 2025 Jan 20;15(1):2. doi: 10.1007/s44197-025-00341-w. J Epidemiol Glob Health. 2025. PMID: 39833495
Low survival due to higher risk of relapse and non-relapse mortality after allogeneic HSCT in ATL compared with AML and ALL.
Tomori S, Morishima S, Kato K, Nakasone H, Nakano N, Eto T, Kawakita T, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Mori Y, Nakamae H, Nagafuji K, Uehara Y, Doki N, Kanda J, Fukuda T, Atsuta Y, Yoshimitsu M; JSTCT ATL Working Group and JSTCT Transplant Complications Working Group. Tomori S, et al. Among authors: kato k. Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00909-1. doi: 10.1016/j.jtct.2025.01.882. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39828057
Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma.
Igaue S, Nozaki R, Utsunomiya D, Kubo Y, Kubo K, Kurita D, Yamamoto S, Miyake M, Ishiyama K, Oguma J, Kato K, Daiko H. Igaue S, et al. Among authors: kato k. Dis Esophagus. 2025 Jan 7;38(1):doae114. doi: 10.1093/dote/doae114. Dis Esophagus. 2025. PMID: 39824221
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.
Imai M, Nakamura Y, Shin S, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Sawada K, Sato A, Kuwata T, Yamashita R, Fujisawa T, Bando H, Ock CY, Fujii S, Yoshino T. Imai M, et al. Among authors: kato k. JCO Precis Oncol. 2025 Jan;9:e2400385. doi: 10.1200/PO-24-00385. Epub 2025 Jan 17. JCO Precis Oncol. 2025. PMID: 39823559 Clinical Trial.
9,951 results